Meyahealth
HomeGeneticsConditionOtulipenia
Back to Condition
Otulipenia
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Otulipenia

Otulipenia is a rare autoinflammatory disease characterized by abnormal, uncontrolled inflammation throughout the body, typically beginning in infancy with recurring episodes of fever, diarrhea, painful swollen joints, and skin rashes, caused by mutations in the OTULIN gene.

Overview

Otulipenia is characterized by abnormal inflammation throughout the body. Inflammation is a normal immune system response to injury and foreign invaders (such as bacteria). However, the uncontrolled inflammation that occurs in otulipenia can damage many of the body's tissues and organs, including the gastrointestinal system, joints, and skin. Disorders such as otulipenia that result from abnormally increased inflammation are known as autoinflammatory diseases.

Signs and Symptoms

Signs and symptoms of otulipenia usually begin within the first few weeks of life, with recurring episodes of:

  • Fever
  • Diarrhea
  • Painful, swollen joints
  • Skin rashes due to inflammation of the layer of fat under the skin (panniculitis), which causes painful red bumps.
  • Abnormal distribution of fatty tissue in their bodies (lipodystrophy) in some individuals.
  • Difficulty growing and gaining weight at the expected rate (failure to thrive) in affected infants.

Damage to the body's tissues and organs caused by inflammation is life-threatening if the condition is not treated.

Frequency

The prevalence of otulipenia is not known. At least four cases have been reported in the medical literature.

Causes & Risk Factors

Otulipenia is caused by mutations in the OTULIN gene. The protein produced from this gene helps control inflammation. Inflammation can be turned on by a cellular process called ubiquitination, in which molecules called ubiquitin are attached to certain proteins. In particular, signaling pathways that lead to inflammation are stimulated by the attachment of chains of ubiquitin molecules linked end-to-end (linear ubiquitin chains). The OTULIN protein helps control inflammation by removing these linear ubiquitin chains.

OTULIN gene mutations that cause otulipenia lead to production of an OTULIN protein with reduced function. As a result, removal of linear ubiquitin chains is impaired, and signaling pathways that cause inflammation are abnormally active. The excessive inflammation that results causes fever, diarrhea, panniculitis, and the other signs and symptoms of otulipenia.

Inheritance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Other Names

  • AIPDS
  • Autoinflammation, panniculitis, and dermatosis syndrome
  • ORAS
  • OTULIN-related autoinflammatory syndrome

Frequently Asked Questions

Otulipenia flare-ups typically involve recurring episodes of high fever, severe diarrhea, painful and swollen joints, and skin rashes (panniculitis, appearing as painful red bumps). While these are characteristic, any sudden worsening of symptoms, signs of severe dehydration due to diarrhea, extreme pain, or lethargy should prompt immediate medical attention. Uncontrolled inflammation can be life-threatening, so prompt intervention is crucial.
Treatment for otulipenia focuses on controlling the abnormal and uncontrolled inflammation. This often involves medications that modulate the immune system, such as anti-inflammatory drugs or biologics that target specific inflammatory pathways. The goal is to reduce the frequency and severity of flare-ups, prevent tissue and organ damage, and improve the child's growth and overall well-being. Treatment plans are highly individualized and managed by specialists like rheumatologists or immunologists.
If the inflammation in otulipenia is not effectively managed, it can lead to significant and permanent damage to various tissues and organs. This includes chronic joint damage, gastrointestinal complications, and issues with growth and weight gain (failure to thrive). In severe cases, uncontrolled inflammation can be life-threatening. Regular monitoring and adherence to treatment are vital to minimize these long-term complications.
Diagnosis of otulipenia often begins with recognizing the characteristic symptoms, especially their onset in infancy and recurring nature. Blood tests may show markers of inflammation. However, a definitive diagnosis relies on genetic testing to identify mutations in the OTULIN gene. This genetic confirmation is essential given the rarity of the condition and to differentiate it from other inflammatory disorders.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ